ZOLL Medical Corp. (Nasdaq:ZOLL) announced on November 18, 2010 that fiscal 2010 revenues were $444.0 million, compared to fiscal 2009 revenues of $385.2 million, an increase of 15%. Revenue results reflected a positive foreign exchange impact of $5 million, approximately half of which related to the Canadian Dollar, compared to fiscal 2009. The results include approximately $18.9 million of revenue derived from our new Temperature Management business, whose assets were acquired from Alsius Corporation in May 2009. Net income for the year was $18.9 million, compared to $9.6 million in the prior year. Diluted earnings per share were $0.87, compared to $0.45 in the prior year. Backlog at the end of the year was approximately $14 million, as compared to $20 million at the end of the prior fiscal year and $14 million at the end of Q3 2010.
ZOLL Medical Corporation, together with its subsidiaries, develops and markets medical devices and software solutions in the United States and internationally.
SavWatt USA, Inc. (Pinksheets:SAVW) pioneers in LED lighting and the Green revolution, announced that in cooperation with the City of Baltimore, SavWatt will receive grant funds from the Maryland Energy Sector Grant. This million dollar grant will offer companies the ability to take LEED certification classes. LEED is an internationally recognized green building certified program. LEED certification important as many new construction and government projects are required to meet LEED standards. It is imperative for building owners, designers, construction firms and real estate developers to further develop their professional skills by obtaining LEED certification. SavWatt USA, Inc. has teamed up with the leaders in LEED training, Clean Edison, to offer this LEED AP certification at SavWatt's Baltimore, MD headquarters.
SavWatt is leading the LED lighting revolution and setting the stage to obsolete the incandescent light bulb through the use of energy-efficient, environmentally friendly LED lighting. SavWatt is a market-leading innovator of LED lighting. SavWatt's product families include LED fixtures, bulbs, Street Lights and Parking Lights. For additional product and company information, please refer to www.savwatt.com. To hear Recorder updates on the company Text SAVW to 46800.
Lam Research Corporation (Nasdaq:LRCX) announced on November 22, 2010. It will present at the Credit Suisse’s 2010 Annual Technology Conference on Wednesday December 1 at 8:15 a.m. Pacific Time. A live webcast of the presentation will be available to the public and can be accessed from the Investors’ section of Lam’s website at www.lamresearch.com. A replay of the webcast will be available for two weeks after the presentation date. Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world’s semiconductor industry. Lam’s common stock trades on The NASDAQ Global Select MarketSM under the symbol LRCX. Lam Research is a NASDAQ-100® company.
Lam Research Corporation engages in the design, manufacture, marketing, and service of semiconductor processing equipment used in the fabrication of integrated circuits.
MusclePharm Corporation (OTCQB:MSLP)
MusclePharm Corporation is pleased to announced a multi-year partnership with the World Bodybuilding and Fitness Federation (WBFF) that will place the company as the title sponsor of the World Famous WBFF through 2014.
The partnership begins in 2011 and MSLP will work closely with the WBFF and its President and CEO, Paul Dillett, who is widely considered one of the greatest bodybuilders in the sport’s history. Dillett, recognized as Canada’s greatest bodybuilder, won numerous bodybuilding titles throughout his illustrious career, and is often regarded as having one of the sport’s most recognizable physiques.
Paul Dillet, President and CEO of WBFF, said, “We believe this partnership will greatly increase the reach of both brands and continue to fuel the record growth both companies have enjoyed over the past few years.”
In four short years, the WBFF has grown to become a popular destination for aspiring professional bodybuilders and fitness competitors. In 2010 alone, participants from more than 25 different countries competed in the WBFF World Championships, which featured many of the world’s top fitness athletes.
MSLP’s President, Cory Gregory, commented, “We are very excited to partner with the WBFF. We believe this relationship will expand our brand by introducing our nutritional supplements, which are 100% free of any banned substances, to a new market.”
“With the recently announced fulfillment agreement, our enhanced operating platform will enable us to improve margins and enable management to focus on partnering opportunities such as WBFF. We believe we are well positioned to achieve very strong growth in 2011 and look forward to leveraging our brand and superior product offerings into new channels and improving our operating margins.”
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MSLP products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. MSLP's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MSLP is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com.
To learn more about MSLP visit: http://www.musclepharm.com
IPC The Hospitalist Company, Inc. (Nasdaq:IPCM) a leading national hospitalist physician group practice company, announced on November 19, 2010 that it has acquired the hospitalist practice of Hospitalists of West Michigan, PC (HOWM) headquartered in Grand Rapids, Michigan. The acquisition represents a further expansion in the Michigan market, where IPC already has a well-established presence. HOWM has an annualized volume of approximately 45,000 patient encounters. R. Jeffrey Taylor, President and COO of IPC, commented, "HOWM is our second acquisition in Michigan this year. This practice group has built strong relationships with the primary care physicians in the Grand Rapids market, and this is a core value for IPC. As a company, we remain focused on working closely with outpatient physicians and specialists in all of the markets we serve.
IPC The Hospitalist Company, Inc., a physician group practice company, provides hospitalist services in the United States. The company, through its affiliated hospitalists, provides, manages, and coordinates the care of hospitalized patients and serves as the inpatient partner of primary care physicians and specialists.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for SavWatt USA, Inc. (OTC:SAVW). Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (OTCQB:MSLP).